Sanofi (SNYNF) EBT (2009 - 2026)
Sanofi (SNYNF) posted EBT of $16.6 billion for Q2 2026, up 14.85% sequentially from $14.4 billion in Q1 2026, and up 20.47% YoY from $13.8 billion in Q2 2025.
Sanofi (SNYNF) EBT (2009 - 2026) Analysis & Trends
Sanofi has reported EBT for 18 years, with the latest figure at $16.6 billion in Q2 2026.
- Quarterly EBT rose 20.47% year-over-year to $16.6 billion in Q2 2026, while the trailing twelve-month figure through Jun 2026 was $88.4 billion (up 91.48% YoY) and the FY2025 annual result came in at $7.2 billion, up 47.71% from the prior year.
- EBT rose to $16.6 billion in Q2 2026 per SNYNF's latest filing, from $14.4 billion in the prior quarter.
- Over five years, EBT peaked at $49.2 billion in Q4 2023 and troughed at $4.9 billion in Q4 2024.
- A 5-year average of $18.1 billion and a median of $13.4 billion in 2023 frame the typical range for EBT.
- The sharpest annual moves came in 2022 and 2024: EBT surged 242236.53% in 2022, then slumped 90.11% in 2024.
- Over 5 years, EBT stood at $40.4 billion in 2022, then rose by 21.65% to $49.2 billion in 2023, then plunged by 90.11% to $4.9 billion in 2024, then jumped by 162.14% to $12.8 billion in 2025, then jumped by 30.01% to $16.6 billion in 2026.
- According to Business Quant data, EBT over the past three periods registered $16.6 billion, $14.4 billion, and $12.8 billion for Q2 2026, Q1 2026, and Q4 2025 respectively.
Peer Comparison
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 16.58 Bn |
| Mar 31, 2026 | 14.44 Bn |
| Dec 31, 2025 | 12.76 Bn |
| Sep 30, 2025 | 44.60 Bn |
| Jun 30, 2025 | 13.77 Bn |
| Mar 31, 2025 | 12.59 Bn |
| Dec 31, 2024 | 4.87 Bn |
| Sep 30, 2024 | 14.94 Bn |
| Jun 30, 2024 | 10.98 Bn |
| Mar 31, 2024 | 11.72 Bn |
| Dec 31, 2023 | 49.20 Bn |
| Sep 30, 2023 | 14.61 Bn |
| Jun 30, 2023 | 12.87 Bn |
| Mar 31, 2023 | 13.01 Bn |
| Dec 31, 2022 | 40.44 Bn |
| Sep 30, 2022 | 13.90 Bn |
| Jun 30, 2022 | 12.62 Bn |
| Mar 31, 2022 | 12.49 Bn |
| Dec 31, 2021 | -16.70 Mn |
| Sep 30, 2021 | 13.43 Bn |